Profile
CDIO VRTX REGN ALNY SGEN ARGX
Company Name Cardio Diagnostics Holdings, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $6.77M $117.98B $57.12B $43.28B $43.15B $34.40B
Employees 0.01K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Meeshanthini V. Dogan Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
CDIO VRTX REGN ALNY SGEN ARGX
Quant Rating Score 3 2 4 1 3 2
Quant Rating Neutral Sell Buy Strong Sell Neutral Sell
Trading
CDIO VRTX REGN ALNY SGEN ARGX
Last Close $4.29 $479.53 $559.76 $322.64 $228.74 $563.31
High 52 $5.35 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 $0.16 $396.64 $482.92 $224.58 $228.74 $461.01
Price vs. 52 Week High -19.81 % -7.2 % -53.42 % -2.79 % 0 % -16.14 %
Price vs. 52 Week Low 2581.25 % 20.9 % 15.91 % 43.66 % 0 % 22.19 %
Total Return
CDIO VRTX REGN ALNY SGEN ARGX
1 Month Return 1.42 % 5.99 % 7.88 % 8.11 % 0 % -2.03 %
3 Month Return 959.26 % -0.97 % 1.01 % 35.69 % 0 % -3.03 %
6 Month Return 539.34 % 17.08 % -19.68 % 35.57 % 0 % -14.16 %
9 Month Return 1942.86 % -0.45 % -44.89 % 13.48 % 0 % 4.96 %
YTD Return 367.83 % 19.08 % -21.42 % 37.11 % 0 % -8.4 %
1 Year Return 680 % -2.56 % -48.18 % 23.61 % 0 % 22 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CDIO VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.33 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -24.81 % -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
CDIO VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM -104.93 % 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -47.67 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM -84.56 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM -49.72 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 100.28 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM -29335.69 % -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM -856.54 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM 2.08 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM - 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM - 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM 1.93 % 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM 0.16 % 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM -3.07 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -3.2 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 574.61 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -26041.63 % -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 104.03 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -856.54 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM -1.26 -93.78 18.91 -574.08 -81.26 -443.33
Price To Operating Cash Flows Ratio TTM -1.27 -120.39 14.52 -954.11 -93.1 -526.76
Price Cash Flow Ratio TTM -1.27 -120.39 14.52 -954.11 -93.1 -526.76
Income Statement (TTM)
CDIO VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 100% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0.01B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.01B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -9.3 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
CDIO VRTX REGN ALNY SGEN ARGX
Long Term Debt $0B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.01B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.01B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
CDIO VRTX REGN ALNY SGEN ARGX
Net Income $-0.01B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 38.35
AARD Aardvark Therapeutics, Inc. Common Stock 12.12
ABCL AbCellera Biologics Inc. 4.005
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.74
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.43
ABPWW 0.0351
ABSI Absci Corporation 2.67
ABUS Arbutus Biopharma Corporation 3.185
ABVC ABVC BioPharma, Inc. 3.96
ABVX Abivax SA American Depositary Shares 8.25
ACAD ACADIA Pharmaceuticals Inc. 20.975
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7541
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.315
ACIU AC Immune SA 2.04
ETFs With Exposure to CDIO
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0.00005 195.9
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00005 150.25
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00005 150.26
VEMPX Vanguard Extended Market Index InstlPlus 0.00005 370.78
Unlock